SVP and Chief Technical Officer Michael J. Labarre sold $348K of Halozyme Therapeutics, Inc.

Sold$348,072

$29.01Price

12,000Shares

−6%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Mon, Jul 20. Filed Mon, Jul 20, 2:33 PM ET, during the session. Not investment advice.